{"paper_id":"37fdbe3a-509f-412b-8413-f51f5487bddb","body_text":"Abstract\nEndometriosis is a benign gynaecological disease characterized by the presence of endometrial tissue outside the uterine cavity, primarily on the pelvic peritoneum and ovaries. The most common clinical features of endometriosis are dysmenorrhea, chronic pelvic pain, pain during intercourse, and infertility. However, the clinical symptoms do not always correlate with the extent of the disease, and for this reason, the diagnosis of the disease is often delayed between 7 and 10 years.\nThis work was performed under the auspices of the Càtedra d’Investigació en Obstetrícia i Ginecologia of the Department of Obstetrics, Gynaecology and Reproductive Medicine, Hospital Universitari Dexeus, Universitat Autònoma de Barcelona.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nD’Hooghe TM, et al. Endometriosis and subfertility: is the relationship resolved? Semin Reprod Med. 2003;21(2):243–54.\nMeuleman C, et al. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009;92(1):68–74.\nAkande VA, et al. Differences in time to natural conception between women with unexplained infertility and infertile women with minor endometriosis. Hum Reprod. 2004;19(1):96–103.\nD’Hooghe TM, et al. Nonhuman primate models for translational research in endometriosis. Reprod Sci. 2009;16(2):152–61.\nde Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2010;376(9742):730–8.\nGonzalez-Foruria I, et al. Dysregulation of the ADAM17/Notch signalling pathways in endometriosis: from oxidative stress to fibrosis. Mol Hum Reprod. 2017;23(7):488–99.\nDuffy JM, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2014;4:CD011031.\nHuman Fertilisation and Embryology Authority. Fertility treatment 2014—Trends and figures. London 2016, 2016.\nCenters for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2015 Assisted reproductive technology national summary report. 2017. Atlanta, 2017.\nGuerriero S, et al. Transvaginal ultrasound vs magnetic resonance imaging for diagnosing deep infiltrating endometriosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(5):586–95.\nHamdan M, et al. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015;21(6):809–25.\nHamdan M, et al. Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(1):79–88.\nRevised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817–21.\nOppenheimer A, et al. Pregnancy rate after first intra cytoplasmic sperm injection- in vitro fertilisation cycle in patients with endometrioma with or without deep infiltrating endometriosis. Int J Fertil Steril. 2013;7(3):207–16.\nBallester M, et al. Deep infiltrating endometriosis is a determinant factor of cumulative pregnancy rate after intracytoplasmic sperm injection/in vitro fertilization cycles in patients with endometriomas. Fertil Steril. 2012;97(2):367–72.\nPolyzos NP, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including approximately 15,000 women. Fertil Steril. 2018;110(4):661–70. e1\nSallam HN, et al. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;1:CD004635.\nDrakopoulos P, et al. Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF/ICSI treatment, according to the rAFS stage? Gynecol Endocrinol. 2018;34(10):884–9.\nRodriguez-Purata J, et al. Endometriosis and IVF: are agonists really better? Analysis of 1180 cycles with the propensity score matching. Gynecol Endocrinol. 2013;29(9):859–62.\nGeorgiou EX, et al. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. Cochrane Database Syst Rev. 2019;2019(11):CD013240.\nChapron C, et al. Management of ovarian endometriomas. Hum Reprod Update. 2002;8(6):591–7.\nRossi AC, Prefumo F. The effects of surgery for endometriosis on pregnancy outcomes following in vitro fertilization and embryo transfer: a systematic review and meta-analysis. Arch Gynecol Obstet. 2016;294(3):647–55.\nGarcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24(3):496–501.\nMuzii L, et al. Antimullerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis. Fertil Steril. 2018;110(5):932–40. e1\nSomigliana E, et al. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications. Fertil Steril. 2012;98(6):1531–8.\nBourdon M, et al. Endometriosis and ART: a prior history of surgery for OMA is associated with a poor ovarian response to hyperstimulation. PLoS One. 2018;13(8):e0202399.\nBarri PN, et al. Endometriosis-associated infertility: surgery and IVF, a comprehensive therapeutic approach. Reprod BioMed Online. 2010;21(2):179–85.\nVillette C, et al. Risks of tubo-ovarian abscess in cases of endometrioma and assisted reproductive technologies are both under- and overreported. Fertil Steril. 2016;106(2):410–5.\nSantulli P, et al. Endometriosis-related infertility: assisted reproductive technology has no adverse impact on pain or quality-of-life scores. Fertil Steril. 2016;105(4):978–87. e4\nCohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108(1):117–24. e5\nChapron C, et al. Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis. Fertil Steril. 2011;95(3):877–81.\nChapron C, et al. Deeply infiltrating endometriosis: pathogenetic implications of the anatomical distribution. Hum Reprod. 2006;21(7):1839–45.\nBourdon M, et al. The deferred embryo transfer strategy improves cumulative pregnancy rates in endometriosis-related infertility: A retrospective matched cohort study. PLoS One. 2018;13(4):e0194800.\nZullo F, et al. Endometriosis and obstetrics complications: a systematic review and meta-analysis. Fertil Steril. 2017;108(4):667–72. e5\nSharma S, et al. Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients. Reprod BioMed Online. 2019;38(1):13–21.\nVercellini P, et al. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29(5):964–77.\nHauzman EE, Garcia-Velasco JA, Pellicer A. Oocyte donation and endometriosis: what are the lessons? Semin Reprod Med. 2013;31(2):173–7.\nMartinez-Conejero JA, et al. Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation. Fertil Steril. 2011;96(4):943–50.\nCobo A, et al. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study. Fertil Steril. 2020;113(4):836–44.\nAuthor information\nAuthors and Affiliations\nCorresponding authors\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2021 International Society of Gynecological Endocrinology\nAbout this chapter\nCite this chapter\nGonzález-Foruria, I., Barri Ragué, P.N. (2021). ART and Endometriosis: Problems and Solutions. In: Genazzani, A.R., Nisolle, M., Petraglia, F., Taylor, R.N. (eds) Endometriosis Pathogenesis, Clinical Impact and Management. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-030-57866-4_11\nDownload citation\nDOI: https://doi.org/10.1007/978-3-030-57866-4_11\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-030-57865-7\nOnline ISBN: 978-3-030-57866-4\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}